article thumbnail

Prescribing shift for Pfizer’s Paxlovid expands access but draws questions

Pharmaceutical Technology

On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. .

Pharmacy 278
article thumbnail

Guinea declares Ebola epidemic following first deaths since 2016

pharmaphorum

The BBC reported that these first deaths from Ebola since 2016 were linked to the burial of a nurse, where four others fell ill with diarrhoea, vomiting and bleeding. Drugs are also available that can increase the survival rate of patients. The post Guinea declares Ebola epidemic following first deaths since 2016 appeared first on.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI in pharma: Can it be used in DTC?

World of DTC Marketing

Drug Discovery and Manufacturing: It helps in the initial screening of drug compounds to the predicted success rate based on biological factors. Precision medicine or next-generation sequencing helps in the faster discovery of drugs and tailored medication for individual patients. . Measuring RNA, DNA quickly.

Doctors 164
article thumbnail

U.S. FDA Extends Review of Pfizer’s New Drug Application for PAXLOVID™

Pfizer

FDA Extends Review of Pfizer’s New Drug Application for PAXLOVID™. FDA Extends Review of Pfizer’s New Drug Application for PAXLOVID™. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for its COVID-19 oral treatment, PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets).

Drugs 69
article thumbnail

How the US’s pending PIE Act will improve patient access to medication

pharmaphorum

7008), which allows manufacturers to share vital information with healthcare payers and plans while treatments are pending Food and Drug Administration (FDA) approval, was passed by the House of Representatives and is awaiting approval in the Senate. The AMCP backed bill (H.R. The history of PIE. Then, of course, guidance is not law.

article thumbnail

On Speakers Programs and PhRMA’s Updated Ethics Code

Intouch Solutions

Last month, the Pharmaceutical Research and Manufacturers of America (PhRMA) “updated and enhanced” its voluntary code of ethics regarding appropriate interactions between the drug industry and U.S. healthcare professionals (HCPs) while marketing pharma products, including speaker programs.

Nurses 52
article thumbnail

Can you trust Turkey-approved Alipza? Is it the same as U.S.-Approved Livalo?

Pharmacy Checkers

This post is mostly a story about a very well manufactured, safe and effective, foreign version of an FDA-approved drug. These drugs are normally far less expensive than the FDA-approved version sold in the U.S. John’s doctor was skeptical of drugs bought online from other countries. Is the drug safe? pharmacies.